Particularly noteworthy is that in patients with both type 2 diabetes and MASLD, after 24 weeks of treatment with a 10 mg dose of efinopegdutide, liver fat content reduced by 72.7%, a result that is superior to the 42.3% reduction achieved with a 1 mg dose of semaglutide, despite a similar overall weight loss being observed with the two interventions
While just over 30% of people on Wegovy made it on their medication to the one-year mark in 2021, the year it was approved for weight loss, that figure had nearly doubled by 2024
Order now and start your journey to flawless skin!
However, the studies listed below should not be interpreted as supportive of any health benefit
For eczema patients, who often have both low vitamin D levels and low antimicrobial peptide expression, supplementation represents one of the most evidence-based adjunct strategies available